Date8 July 2021
About the event
Attendees were introduced to the concepts, practical and regulatory implications of emerging technologies for Point of Care Manufacture of Medicinal Products.
This webinar would particularly interest Chief Pharmacists & their deputies, QA and technical services, radiopharmacy teams, MSOs and senior clinical pharmacists.
Why it’s important
It’s important to understand the role of pharmacy professionals in governance of these emerging and innovative products.
What was covered
The session included:
- An overview of the innovative medicines development pathway and product life cycle from design through development to implementation
- Defining Point of Care Medicines and the role of pharmacy
- The new Point of Care regulatory framework from the MHRA
A range of speakers ran this event from SPS and other organisations
You can read more about our SPS speakers by following the links.
We were joined during the session by:
Unit Manager Inspectorate Strategy & Innovation, MHRA
Chief Scientific & Regulatory Officer, Biotherapy Services Ltd
Chief Pharmacist/Clinical Director, King’s College Hospital NHS Foundation Trust
The MHRA document on POC Manufacture has been included for reference.
Slides from the presentation are now available below
Contact the Admin Team if you have any questions